Louise Frederika Kooij, Chief Accounting Officer at NewAmsterdam Pharma Co N.V. (NAMS), sold 40,000 shares at $30.20 ($1.2M) on 2026-06-22, disclosed to the SEC on 2026-06-24.
Scheduled sale ($1.2M) by Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.20 | 39,700 | $1.2M | 99.2% |
| 2 | $30.73 | 300 | $9K | 0.8% |
| Total | $30.20 avg | 40,000 | $1.2M | 100% |
| Filing → |
| NAMS | SELL | 2026-01-29 | $2.3M | — | Filing → |
| NAMS | SELL | 2026-01-27 | $2.4M | — | Filing → |
| NAMS | SELL | 2026-01-07 | $88K | — | Filing → |